Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

G Protein-coupled Receptors01:15

G Protein-coupled Receptors

20.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
20.1K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

2.6K
2.6K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

6.0K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
6.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

5.1K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
5.1K
Phosphodiester Linkages01:01

Phosphodiester Linkages

114.9K
Overview
Phosphodiester bond forms when a phosphoric acid molecule (H3PO4) links with two hydroxyl groups (–OH) of two other molecules, forming two ester bonds. Two water molecules are released in this process. The phosphodiester bond is commonly found in nucleic acids (DNA and RNA) and plays a critical role in their structure and function.
Phosphodiester Bonds Link Nucleotides Together
DNA and RNA are polynucleotides or long chains of nucleotides that are linked together. A nucleotide is...
114.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From empirical screening to lipid trolling: the evolution of extrahelical allosteric modulators of A<sub>1</sub> and A<sub>3</sub> adenosine receptors.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Same author

MRS2339, a cardiac P2X4 receptor nucleotide activator, improves systolic function in heart failure.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Same author

Perturbing <i>O</i>-GlcNAcase Modulates the Expression and Distribution of Galectin-3.

Cells·2026
Same author

Structural basis for the synaptic adhesion protein ELFN1-mediated modulation of mGlu7.

Protein & cell·2026
Same author

Subtype-dependent arrestin engagement of the metabotropic glutamate receptors.

Nature communications·2026
Same author

Ligand binding modes of the bitter taste receptor T2R14 and T2R46.

Nature structural & molecular biology·2026

Related Experiment Video

Updated: Apr 15, 2026

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels
16:36

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels

Published on: May 18, 2009

15.3K

Nucleotides Acting at P2Y Receptors: Connecting Structure and Function.

Kenneth A Jacobson1, Silvia Paoletta2, Vsevolod Katritch2

  • 1Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland (K.A.J., S.P., Z.-G.G., E.K.); The Bridge Institute, Dana and David Dornsife School of Letters, Arts, and Sciences, University of Southern California, Los Angeles, California (V.K., R.C.S.); and Chinese Academy of Sciences Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (B.W., Q.Z.) kajacobs@helix.nih.gov.

Molecular Pharmacology
|April 4, 2015
PubMed
Summary

Eight G protein-coupled P2Y receptor (P2YR) subtypes mediate physiology. Recent X-ray structures of P2Y12R and P2Y1R provide insights for structure-based drug design targeting these important receptors.

More Related Videos

Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time
08:33

Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time

Published on: March 11, 2021

2.4K
Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells
11:47

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells

Published on: April 3, 2019

9.9K

Related Experiment Videos

Last Updated: Apr 15, 2026

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels
16:36

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels

Published on: May 18, 2009

15.3K
Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time
08:33

Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time

Published on: March 11, 2021

2.4K
Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells
11:47

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells

Published on: April 3, 2019

9.9K

Area of Science:

  • Pharmacology
  • Structural Biology
  • Biochemistry

Background:

  • Eight G protein-coupled P2Y receptor (P2YR) subtypes are key physiological mediators.
  • P2YRs are activated by various nucleotides like ATP, ADP, UTP, UDP, and UDP glucose.
  • Understanding P2YR structure is crucial for developing targeted therapeutics.

Purpose of the Study:

  • To elucidate the structural basis of P2YR activation and ligand recognition.
  • To facilitate structure-based drug design for P2YR modulators.
  • To advance the understanding of P2YR subfamily structural requirements.

Main Methods:

  • X-ray crystallography of ligand complexes for P2Y12R and P2Y1R.
  • Mutagenesis studies to probe ligand recognition and receptor activation.
  • Comparative analysis of structural features and nucleotide binding.

Main Results:

  • High-resolution X-ray structures of Gi-coupled P2Y12R and Gq-coupled P2Y1R ligand complexes were determined.
  • Unusual binding site features were identified, complementing mutagenesis data.
  • Structural requirements for nucleotide agonist recognition were clarified, emphasizing base recognition specificity.

Conclusions:

  • Recent structural findings provide significant insight into the P2YR family.
  • These structures are valuable for the rational design of novel P2YR-targeting drugs.
  • Further research can leverage these insights for therapeutic advancements.